Recruiting at 4 sites No phase Epilepsy

Epilepsy study: Photobiomodulation

Official title An Examination of Whether Infrared Light Therapy Can Reduce Stress in People With Epilepsy

ClinicalTrials.gov ID: NCT07509177

What this study is testing

What it's testing
This study is testing whether infrared light therapy can lower stress in people with epilepsy.
Who it's for
You may be able to join if you have epilepsy and are willing to attend regular sessions.
What's involved
You will receive infrared light therapy at the clinic three times a week for 30 minutes each session. You will also have metabolic tests and wear an Õura ring to track your data.
Time commitment
The study lasts about 15 weeks, with 3 sessions per week and periodic tests.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • \>18 YO
  • Epilepsy - medical diagnosis with at least one seizure within the past 6 months: diagnosis to be obtained from medical records from the treating...
  • Agreement to maintain or reduce medication regimen (based upon prescribers' advice)
  • Available for intake, baseline, post-treatment, 6-month follow-up assessments, and 45 sessions of PBM
  • \< 17 YO
See the full eligibility criteria
Who can join
  • \>18 YO
  • Epilepsy - medical diagnosis with at least one seizure within the past 6 months: diagnosis to be obtained from medical records from the treating physician by signature of HIPAA-compliant medical release form
  • Agreement to maintain or reduce medication regimen (based upon prescribers' advice)
  • Available for intake, baseline, post-treatment, 6-month follow-up assessments, and 45 sessions of PBM
  • \< 17 YO
  • Substance use
  • Personality disorders
  • Heavy metal toxicity
  • Mold toxicity
  • Metabolic measures thresholded based on participant type
  • Increase in current medication (dosage and/or type)
  • No new medications prescribed (reduction as prescribed by prescribing physician OK)
  • Current brain bleed
  • Acute TBI within the last 12 months
  • History of neuromodulation, including ECT
  • Brain implants/pumps/shunts
  • History of brain surgery
  • Hormone replacement therapy for menopause or gender transition
  • Untreated sleep disorders

The study team makes the final eligibility decision.

Where it is enrolling

  • North Miami, Florida, United States
  • Cincinnati, Ohio, United States
  • Warren, Ohio, United States
  • Houston, Texas, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at North Miami, Florida, United States; Cincinnati, Ohio, United States; Warren, Ohio, United States; Houston, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.